Oct 29 (Reuters) – Enanta Pharmaceuticals Inc: * ENANTA PHARMACEUTICALS INC: IN PATENT INFRINGEMENT ACTION AGAINST PFIZER RELATED TO INFRINGEMENT, UPC RULES '265 PATENT INVALID – SEC FILING * ENANTA
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Will Dunham Oct 29 (Reuters) - Patrick Stewart, who rose from poverty in England…
DAVITA REPURCHASED 382,563 SHARES FROM BERKSHIRE HATHAWAY, WHICH STILL OWNED ABOUT 28.3 MILLION SHARES FOLLOWING…
VIDEO SHOWS: SOUNDBITES FROM BRAZIL COACH CARLO ANCELOTTI RESENDING WITH COMPLETE SCRIPT SHOWS: RIO DE…
SAO PAULO, Oct 29 (Reuters) - Brazilian state-run oil firm Petrobras said on Thursday it…
By Deborah Mary Sophia and Greg Bensinger Oct 29 (Reuters) - Amazon.com on Thursday reported…
By Deborah Mary Sophia and Greg Bensinger Oct 29 (Reuters) - Amazon.com on Thursday reported…